Drugs / TIV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01146119 Comparator | Jul 2010 → May 2011 | influenza | BiondVax Pharmaceuticals ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01146119 ↗ |
| Modality | Vaccine | “commercial seasonal trivalent vaccine” NCT01146119 ↗ |
| Route | Intramuscular | “Intramuscular Influenza Vaccine” NCT01146119 ↗ |